Slowing the Titanic: China’s Epic Struggle with Tobacco

Abstract

China is home to a third of the world's smokers and, correspondingly, to a third of the world's cases of lung cancer. Beginning in the mid-1990s, a generation or so later than in many Western countries, the Chinese government commenced measures to control tobacco, limiting advertising, banning smoking in many public venues, and increasing taxation. At the time of this review, there are signs that these policies are having some effect, but hundreds of millions of Chinese continue to smoke and rates of diagnosis of lung cancer continue to rise. There is much work to be done and much premature death to be suffered before the epidemic is slowed to the levels reached in Australia or the United States. This article aims to provide, particularly for practicing lung cancer clinicians, a description of patterns of smoking in China, the lung cancer epidemic there, and the stimuli for and barriers to tobacco control imposed by the highly complex and unique regulatory setting of the Chinese tobacco industry. A particular challenge in developing this description has come from the variability of studies published about a huge nation that has enormous diversity in wealth, education, urbanization, and tradition. The studies vary because the data vary. Much information on lung cancer and smoking rates in China comes, for example, from studies of cohorts that may number in the millions yet represent only a small percentage of the population and sometimes only a tiny geographic area of such a vast nation. National registry data on lung cancer in China do not yet cover even a fifth of the national population. Even so, we argue that several major trends can be identified: (1) more than 50% of men smoke regularly; (2) there are more than 300 million smokers in China; (3) almost half a million new cases of lung cancer are diagnosed in China each year; (4) secondhand smoking is a significant problem in China (as elsewhere), accounting for a high proportion of lung cancer cases among women, most of whom do not smoke; (5) corrected for age and sex, lung cancer rates in the Chinese population are as least as high as in Western countries and arguably higher; and (6) a shift over time from squamous cell carcinoma (SCC) to adenocarcinoma is occurring in parallel with that noted in Western populations. Looking to the future, measures to control tobacco in China are strengthening but remain relatively weak. The reinforcement of control is hampered by the circumstance that the tobacco industry remains a powerful state-owned monopoly that participates, through its membership of key government bodies, in the processes that oversee the implementation of tobacco control. The conflict between the government's dual responsibilities for both the production and distribution of tobacco and for the implementation of tobacco control carries inherent contradictions and bias. How long the Chinese government chooses to live with these contradictions will determine how quickly the smoking of tobacco will be reduced and how soon the burden of disease that tobac...

Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis

“…A total of 1219 patients were identified. We excluded 130 patients from this study for the following reasons [1]: 122 patients were excluded because they received treatment before EGFR or ALK status detection [2]; 4 patients were excluded because their pathological examination results from different tumor sites suggested different pathological types or could not be categorically classified as a single pathological type; and [3] 4 patients were excluded because they had a history of another cancer. Patient clinical characteristics including age, sex, smoking history, and histopathology were recorded.…”

“…Lung cancer will account for one-quarter of all cancerrelated deaths in 2019 in America [1], and one-third of the total number of cases of lung cancer worldwide are in China [2]. For the past few decades, scientists have been working to develop new drugs and treatments to minimize the side effects of current treatments and achieve better results [3e7].…”

The association between outdoor air pollution and lung cancer risk in seven eastern metropolises of China: Trends in 2006-2014 and sex differences

“…Besides air pollution, there is a lot of risk factor for lung cancer, such as smoking ( 58 ), family history of lung cancer, and so on, which were the confounders. More than 50% of men smoke in China, and there are more than 300 million smokers in China ( 59 ). Smoking and air pollution combined to account for the elevated rates of lung cancer mortality in Shenyang of China ( 60 ).…”

Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients

“…Lung cancer is the most common type of cancer in the world. Onethird of global lung cancer cases are in China, 1 ranking first in morbidity and mortality. 2,3 Non-small cell lung cancer (NSCLC) is the predominant type of lung cancer, accounting for approximately 80%-85%, 4,5 of which adenocarcinoma is one of the most common histopathological types.…”